TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2261941

Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg t.i.d.
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 540460

Group type: EXPERIMENTAL
Intervention: 160 mg of long-acting propranolol
Number of subjects: 2

Group type: COMPARATOR
Intervention: 160 mg of standard propranolol
Number of subjects: 2

Group type: COMPARATOR
Intervention: 400 mg of sotalol
Number of subjects: 2

Group type: COMPARATOR
Intervention: 160 mg of oxprenolol
Number of subjects: 2

Group type: COMPARATOR
Intervention: 160 mg of slow-release oxprenolol
Number of subjects: 2
Study: 31928088

Group type: EXPERIMENTAL
Intervention: Hip Fracture Unit (HFU)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 276
Study: 31805840

Group type: EXPERIMENTAL
Intervention: Narrative group therapy
Number of subjects: 85
Study: 28573683

Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25201555

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 56

Group type: COMPARATOR
Intervention: No abdominal binder (control)
Number of subjects: 56
Study: 24782235

Group type: EXPERIMENTAL
Intervention: Lavender scent
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Instrumental music
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both scent and music
Number of subjects: 117

Group type: COMPARATOR
Intervention: No scent and music (control condition)
Number of subjects: 117
Study: 22950513

Group type: EXPERIMENTAL
Intervention: 90% resting motor threshold rTMS
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20% resting motor threshold rTMS
Number of subjects: 60
Study: 18615497

Group type: EXPERIMENTAL
Intervention: CBT‐G/antidepressant combination
Number of subjects: 45

Group type: COMPARATOR
Intervention: Antidepressant alone
Number of subjects: 45
Study: 17501760

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alpha‐2b
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional IFN alpha‐2b
Number of subjects: 52
Study: 15241906

Group type: EXPERIMENTAL
Intervention: Clearfil Liner Bond 2, a 2‐step self‐etching primer (n = 46)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: One Coat Bond, a one bottle total‐etch system applied with one coat (n = 46)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Prompt‐L‐Pop, a 1‐step self‐etching primer ('all‐in‐one') (n = 52)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sclerotic lesions
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-sclerotic lesions
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diamond bur-roughened lesions
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-roughened lesions
Number of subjects: 90
Study: 11755018

Group type: EXPERIMENTAL
Intervention: Oxidative DNA damage assessment in AD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxidative DNA damage assessment in age-matched controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repair capacity assessment in AD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repair capacity assessment in age-matched controls
Number of subjects: 0
Study: 9673660

Group type: EXPERIMENTAL
Intervention: Spatial working memory tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Object working memory tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perceptual control tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Working memory tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shape task
Number of subjects: 0
Study: 10690161

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich, protein-poor (CR/PP) diet
Number of subjects: 43

Group type: COMPARATOR
Intervention: Protein-rich, carbohydrate-poor (PR/CP) diet
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Uncontrollable stress
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Stress tasks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Diet, stress-proneness and stress-controllability interaction
Number of subjects: 43
Study: 1995917

Group type: EXPERIMENTAL
Intervention: Total fat intake (77 g per day)
Number of subjects: 56337
Study: 12265806

Group type: EXPERIMENTAL
Intervention: Hydron-coated Spring Coil
Number of subjects: 464

Group type: COMPARATOR
Intervention: Plain Spring Coil
Number of subjects: 464
Study: 31565242

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 747

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 747
Study: 29381543

Group type: EXPERIMENTAL
Intervention: SAPB‐T45K
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control
Number of subjects: 46
Study: 26787016

Group type: EXPERIMENTAL
Intervention: Ready-made spectacles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Custom spectacles
Number of subjects: 0
Study: 24735885

Group type: EXPERIMENTAL
Intervention: GLP-1 + PYY3-36
Number of subjects: 25

Group type: COMPARATOR
Intervention: PYY3-36
Number of subjects: 25

Group type: COMPARATOR
Intervention: GLP-1
Number of subjects: 25

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 25
Study: 22403770

Group type: EXPERIMENTAL
Intervention: Sequential intervention
Number of subjects: 3473

Group type: EXPERIMENTAL
Intervention: Simultaneous intervention
Number of subjects: 3473

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 3473
Study: 20088721

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 179

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 179

Group type: COMPARATOR
Intervention: Conversion from spinal to general anaesthesia
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Assisted ventilation
Number of subjects: 179
Study: 17901162

Group type: EXPERIMENTAL
Intervention: Nurse led intermediate care package including initial pulmonary rehabilitation, self‐management education, written COPD action plan, monthly telephone calls, and 3 monthly home visits by a specialist nurse for 2 years
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 122
Study: 16823355

Group type: EXPERIMENTAL
Intervention: Maltodextrins ingestion (0.7 g x kg(-1) body mass)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate free placebo
Number of subjects: 10
Study: 12798791

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10590187

Group type: EXPERIMENTAL
Intervention: Aspirin therapy (81 or 325 mg)
Number of subjects: 32
Study: 9547130

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antidepressants (general)
Number of subjects: 0
Study: 8396749

Group type: EXPERIMENTAL
Intervention: Simvastatin 5 mg evening dose for 8 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 3453200

Group type: EXPERIMENTAL
Intervention: Quit Kit (self-administered smoking cessation program)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Delayed intervention (Control group)
Number of subjects: 207
Study: 31689737

Group type: EXPERIMENTAL
Intervention: Neuronavigation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ultrasound
Number of subjects: 38
Study: 29457363

Group type: EXPERIMENTAL
Intervention: Double-incision, three-port laparoscopic appendectomy (DILA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (CLA)
Number of subjects: 60
Study: 27447719

Group type: EXPERIMENTAL
Intervention: MF102 4 g/day
Number of subjects: 30
Study: 24445656

Group type: EXPERIMENTAL
Intervention: Glargine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 74
Study: 22448994

Group type: EXPERIMENTAL
Intervention: Video plus verbal feedback
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Verbal feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: Experiential feedback
Number of subjects: 54
Study: 19949360

Group type: EXPERIMENTAL
Intervention: Pentavalent human-bovine reassortant rotavirus vaccine
Number of subjects: 2956

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2956
Study: 17924887

Group type: EXPERIMENTAL
Intervention: Format A (two pieces of strength information different from those in the instruction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Format B (all three pieces in a random sequence)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Format C (all three pieces in a fixed sequence)
Number of subjects: 0
Study: 15564386

Group type: EXPERIMENTAL
Intervention: Relaxation therapy with an audiotape of classical music and ocean sounds during CNB
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 0.5-mg of alprazolam administered orally 15 minutes before CNB
Number of subjects: 143

Group type: COMPARATOR
Intervention: No anxiety intervention (usual care group)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: All groups (usual care, relaxation, medication)
Number of subjects: 143
Study: 11983663

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (B)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine (R)
Number of subjects: 51
Study: 8038232

Group type: EXPERIMENTAL
Intervention: NADPH-oxidase activation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electron transfer mechanisms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Molecular pathology
Number of subjects: 0
Study: 3069051

Group type: EXPERIMENTAL
Intervention: Nebulised beclomethasone dipropionate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31474753

Group type: EXPERIMENTAL
Intervention: EFD 0.05 mJ/mm2, two sessions per week (Group A)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EFD 0.05 mJ/mm2, three sessions per week (Group B)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EFD 0.10 mJ/mm2, two sessions per week (Group C)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EFD 0.10 mJ/mm2, three sessions per week (Group D)
Number of subjects: 97
Study: 31444542

Group type: EXPERIMENTAL
Intervention: Pro Seal®
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Opal®Seal™
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Protecto®CaF2Nano
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Transbond™ XT
Number of subjects: 15
Study: 28341877

Group type: EXPERIMENTAL
Intervention: Daily prednisolone at 0.5 mg/kg for 5 days during URTI
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo for 5 days during URTI
Number of subjects: 48
Study: 25605425

Group type: EXPERIMENTAL
Intervention: Air-abrasive device (AAD) with amino acid glycine powder
Number of subjects: 25

Group type: COMPARATOR
Intervention: Mechanical debridement (MDA) using carbon curettes and antiseptic therapy with chlorhexidine digluconate
Number of subjects: 25
Study: 23312291

Group type: EXPERIMENTAL
Intervention: neuropsychological computer training for 14 days, 25‐35 min per day
Number of subjects: 43

Group type: COMPARATOR
Intervention: standard treatment according to Federal and local medical recommendations
Number of subjects: 43
Study: 22070868

Group type: EXPERIMENTAL
Intervention: Panitumumab in combination with oxaliplatin- or irinotecan-based chemotherapy
Number of subjects: 1124
Study: 19849685

Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 86

Group type: COMPARATOR
Intervention: CTrach
Number of subjects: 86
Study: 16205905

Group type: EXPERIMENTAL
Intervention: 150 ug clonidine intra-articularly
Number of subjects: 69

Group type: COMPARATOR
Intervention: 150 ug clonidine intravenously
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 14998222

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11419380

Group type: EXPERIMENTAL
Intervention: Preidentification questions including a new question about belief in ability to reject a target-absent lineup
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 138
Study: 9240888

Group type: EXPERIMENTAL
Intervention: 5-Hydroxy-3-indole acetic acid (5-OH IAA) levels in colicky infants
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (10 subjects)
Number of subjects: 16
Study: 8100428

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2 micrograms/kg and atipamezole 50 micrograms/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2 micrograms/kg and saline
Number of subjects: 72

Group type: COMPARATOR
Intervention: Midazolam 0.15 mg/kg and saline
Number of subjects: 72
Study: 3209717

Group type: EXPERIMENTAL
Intervention: DA agonist (bromocriptine 5 mg orally)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DA antagonist (haloperidol 5 mg intravenously)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cholinergic agonist (physostigmine 2 mg intravenously)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cholinergic antagonist (benztropine 4 mg intravenously)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 15
Study: 31302525

Group type: EXPERIMENTAL
Intervention: MARIGOLD intervention
Number of subjects: 137

Group type: COMPARATOR
Intervention: Daily emotion reporting
Number of subjects: 137

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: MARIGOLD plus online discussion board (ODB)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: MARIGOLD plus virtual badges (VB)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: MARIGOLD plus facilitator contact (FC)
Number of subjects: 137
Study: 28315016

Group type: EXPERIMENTAL
Intervention: Sling training exercises
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 50
Study: 25558034

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT)
Number of subjects: 21
Study: 23627498

Group type: EXPERIMENTAL
Intervention: Frequency format (X out of 100)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Frequency format plus graphical display (10 × 10 human icons)
Number of subjects: 154
Study: 21295835

Group type: EXPERIMENTAL
Intervention: FSH (25 mg im, twice daily for 4 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: eCG (1000 IU as a single i.m. dose)
Number of subjects: 32
Study: 19703336

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 17768187

Group type: EXPERIMENTAL
Intervention: Accelerated preoperative and postoperative rehabilitation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard rehabilitation (control group)
Number of subjects: 100
Study: 15117400

Group type: EXPERIMENTAL
Intervention: Quetiapine (QTP) + Lithium (Li) or Divalproex (DVP)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo (PBO) + Lithium (Li) or Divalproex (DVP)
Number of subjects: 191
Study: 11471907

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Combination of melatonin 5 mg and zolpidem 10 mg
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 9555553

Group type: EXPERIMENTAL
Intervention: Epirubicin (40 mg/ml in normal saline) administered six times within 4 weeks after transurethral resection, followed by 11 additional monthly instillations of epirubicin
Number of subjects: 148

Group type: COMPARATOR
Intervention: Epirubicin (40 mg/ml in normal saline) administered six times within 4 weeks after transurethral resection
Number of subjects: 148
Study: 8177458

Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Estro-progestin therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 40
Study: 3308192

Group type: EXPERIMENTAL
Intervention: Orbital cobalt irradiation combined with retrobulbar methylprednisolone acetate (14 bilateral injections at 20-30 d intervals)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Combined therapy with systemic corticosteroids and orbital radiotherapy
Number of subjects: 44
Study: 31774544

Group type: EXPERIMENTAL
Intervention: Micronized-isotretinoin 32 mg (fed state)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Lidose-isotretinoin 40 mg (fed state)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Micronized-isotretinoin 32 mg (fasted state)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Lidose-isotretinoin 40 mg (fasted state)
Number of subjects: 89
Study: 29506967

Group type: EXPERIMENTAL
Intervention: Self-administered Web-based questionnaires (SAQ-Web)
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Self-administered paper-based questionnaires (SAQ-paper)
Number of subjects: 11140
Study: 28231779

Group type: EXPERIMENTAL
Intervention: Anatomical reduction and fixation of the posterior fragment via the posterolateral approach (n=42)
Number of subjects: 84

Group type: COMPARATOR
Intervention: No fixation of the posterior fragment (n=42)
Number of subjects: 84
Study: 25732095

Group type: EXPERIMENTAL
Intervention: Choice group (participants who selected the color of golf balls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice group (participants who made choices unrelated to the practice task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoked group (participants who received the same colored golf balls as the choice group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoked group (participants who were informed about subsequent tasks and painting)
Number of subjects: 0
Study: 23941667

Group type: EXPERIMENTAL
Intervention: DSL protocol for occupational therapists
Number of subjects: 124

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 124
Study: 22087067

Group type: EXPERIMENTAL
Intervention: Virtual social facilitation with competitive avatars
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline exercise effort (pre-avatar)
Number of subjects: 14
Study: 18337740

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 0
Study: 16735793

Group type: EXPERIMENTAL
Intervention: 400 microg misoprostol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Misoprostol and Placebo
Number of subjects: 40
Study: 14671175

Group type: EXPERIMENTAL
Intervention: 1000 mg/6 wk TU plus 20 mg/d CPA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1000 mg/8 wk TU plus 2 mg/d CPA
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1000 mg/8 wk TU plus placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study: 10882331

Group type: EXPERIMENTAL
Intervention: 1 mg granisetron
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 2 mg granisetron
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 1 mg granisetron + DEX
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 2 mg granisetron + DEX
Number of subjects: 97
Study: 8993943

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ciprofibrate (100 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Simvastatin and Ciprofibrate combination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 1730327

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) + ethinyl estradiol (E2)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Human menopausal gonadotropin
Number of subjects: 4

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 4
Study: 3881968

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (0.75 mg, 1.5 mg, or 2.25 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 30316547

Group type: EXPERIMENTAL
Intervention: Individualised manual therapy plus guideline-based advice (10 sessions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Advice alone (2 sessions)
Number of subjects: 64
Study: 29199629

Group type: EXPERIMENTAL
Intervention: SNAP-Ed intervention
Number of subjects: 328
Study: 24189485

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation
Number of subjects: 65
Study: 26462353

Group type: EXPERIMENTAL
Intervention: Sommerlad technique
Number of subjects: 54
Study: 22556131

Group type: COMPARATOR
Intervention: Suprasensory stimulation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Subsensory stimulation
Number of subjects: 15
Study: 20838035

Group type: EXPERIMENTAL
Intervention: Diet V (increased vegetable consumption)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Diet C (increased cereal consumption)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Increased total calcium intake among women with initial calcium intake below the 50th percentile
Number of subjects: 57
Study: 16236320

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Lithium (300-1800 mg/d)
Number of subjects: 401
Study: 15124783

Group type: EXPERIMENTAL
Intervention: Adhesion primer (Composite Activator) and resin (CA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silane (EspeSil) and resin (SIL-MP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silane, adhesive primer, and resin (Clearfil Repair) (CF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Air particle-abrading (CoJet), silane, and resin (CJ-SIL-MP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Resin (Scotchbond Multipurpose Resin) only
Number of subjects: 60
Study: 11822473

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (0.9 g x kg lean tissue mass(-1) x day(-1); n = 17)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (0.9 g maltodextrin x kg lean tissue mass(-1) x day(-1); n = 14)
Number of subjects: 31
Study: 9793665

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 90